Clinical Trial Update: A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545 [Phase 1]

View source ↗

Summary

This Phase 1 multicenter trial update reports on the safety and tolerability of a single-dose MEDI-545 in adults with chronic plaque psoriasis, and notes the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Plaque

Drugs mentioned

• MEDI-545

Snippet

Sponsor: MedImmune LLC | Conditions: Chronic Plaque Psoriasis | Phase 1 | Status: COMPLETED